Individualized Medicine

Selected news for the healthcare topic - Individualized Medicine, collected since 10/2017. There are 334 items in the archive. This healthcare topic shares news with Mayo Clinic, Precision Medicine, COVID-19 and many others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/2/2022 Science Saturday: Nanopore sequencing method rapidly detects, identifies antibiotic-resistant microbes, Mayo Clinic research shows Mayo Clinic ... million people worldwide died in 201902724-0/fulltext :~:text=On%20the%20basis%20of%20our,deaths%20attributable%20to%20bacterial%20AMR.) from antibiotic-resistant infections.In response, a team of researchers from Mayo Clinic’s Center for Individualized Medicine has developed a sequencing technology to rapidly detect and identify microbes and antibiotic-resistant phenotypes in a single test. The innovative nanopore sequencing method is published in Surgery00998-3/fulltext) and mSphere ,“We demonstrated that ...
3/18/2022 New discovery points to potential drug targets for ASXL1-mutant chronic myelomonocytic leukemia | dispatchist.com dispatchist.com New research from Mayo Clinic's Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia -; an uncommon type of cancer of the bone marrow -; have distinctive epigenetic changes that can activate harmful genes and cause the cancer to grow faster. New research from Mayo Clinic's Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia -; an uncommon type of cancer of the bone marrow ...
3/18/2022 Mayo Clinic discovery in bone marrow cancer points to potential drug targets pressreleasepoint.com Mayo Clinic discovery in bone marrow cancer points to potential drug targetsROCHESTER, Minn. — New research from Mayo Clinic's Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia — an uncommon type of cancer of the bone marrow — have distinctive epigenetic changes that can activate harmful genes and cause the cancer to grow faster. The ASXL1 genetic mutation also can transform the disease into ...
1/27/2022 n-Lorem Foundation Receives $1 Million Donation From Alexion to Develop and Provide Free Individualized Medicines to Nano-rare Patients | Business Wire Business Wire ... has made a donation of $1 million.“At Alexion, we are committed to supporting patients and their families affected by rare diseases. With this donation we seek to support n-Lorem’s development of individualized medicines one nano-rare patient at a time,” said Wendy Erler, Vice President, Patient Advocacy, Alexion.“Nano-rare patients have genetic diseases that often are unique to a single individual in the world. Today ...
1/27/2022 n-Lorem Foundation Receives $1 Million Donation From Alexion to Develop and Provide Free Individualized Medicines to Nano-rare Patients Yahoo News ... has made a donation of $1 million."At Alexion, we are committed to supporting patients and their families affected by rare diseases. With this donation we seek to support n-Lorem’s development of individualized medicines one nano-rare patient at a time," said Wendy Erler, Vice President, Patient Advocacy, Alexion."Nano-rare patients have genetic diseases that often are unique to a single individual in the world. Today ASO ...
1/27/2022 n-Lorem Foundation Receives $1 Million Donation From Alexion to Develop and Provide Free Individualized Medicines to Nano-rare Patients | Business | The Daily News galvnews.com ... has made a donation of $1 million.“At Alexion, we are committed to supporting patients and their families affected by rare diseases. With this donation we seek to support n-Lorem’s development of individualized medicines one nano-rare patient at a time,” said Wendy Erler, Vice President, Patient Advocacy, Alexion.“Nano-rare patients have genetic diseases that often are unique to a single individual in the world. Today ...
1/27/2022 n-Lorem Foundation Receives $1 Million Donation From Alexion to Develop and Provide Free Individualized Medicines to Nano-rare Patients | Business | Maryville Daily Forum maryvilleforum.com ... has made a donation of $1 million.“At Alexion, we are committed to supporting patients and their families affected by rare diseases. With this donation we seek to support n-Lorem’s development of individualized medicines one nano-rare patient at a time,” said Wendy Erler, Vice President, Patient Advocacy, Alexion.“Nano-rare patients have genetic diseases that often are unique to a single individual in the world. Today ...
1/1/2022 Science Saturday: 10 significant Mayo Clinic Center for Individualized Medicine studies of 2021 Mayo Clinic By Susan MurphyScience Saturday: 10 significant Mayo Clinic Center for Individualized Medicine studies of 2021It has been an impactful year of genomic and multi-omic research and scientific discoveries in Mayo Clinic's Center for Individualized Medicine . While much focus in 2021 was centered on advancing the knowledge of COVID-19, Mayo scientists and physicians have also worked to develop individualized treatments, prevention measures and diagnostics for patients with ...
12/21/2021 How Dr. Eric Topol recommends using rapid Covid tests amid omicron wave CNBC ... we're going to use rapid tests, they've got to be as close proximal to the time of the event as possible, and that would include travel," he said. Topol, an expert in genomics and individualized medicine , said so far the data suggests omicron mostly causes mild sickness in people who have received the Covid vaccine, including a booster shot. "With omicron, there's a lot of breakthroughs," Topol said, suggesting it ...
12/18/2021 Science Saturday: Identifying inherited gene mutations in pancreatic cancer can lead to targeted therapies, better survival Mayo Clinic ... 1 in 6 people with pancreatic cancer harbor inherited genetic mutations.Identifying hereditary gene mutations in pancreatic cancer can help determine individualized treatments and potentially prolong survival, according to new Mayo Clinic Center for Individualized Medicine research.In the study, which was published in Clinical and Translational Gastroenterology , nearly 1 in 6 people diagnosed with pancreatic cancer were found to have an inherited cancer-related gene mutation that likely predisposed ...
12/17/2021 Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome BMJ ... acquisition and analysis of data, conception, design and study supervision. All authors revised the manuscript critically for intellectual content and approved the final version. Funding This work was supported by Mayo Clinic Center of Individualized Medicine Welch Award. Competing interests CV-S, AMK, MBH, YG, JRM, AA and MH have no competing interests to disclose. TJK has a patent AQP4-IgG with royalties paid, a patent KLHL11, septin 5 and ...
12/15/2021 De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability BMJ ... médicale d’Alsace (IGMA), Laboratoire de Diagnostic Génétique , Hôpitaux universitaires de Strasbourg , Strasbourg , Alsace , France 2 Department of Quantitative Health Sciences Research , Mayo Clinic , Rochester , Minnesota , USA 3 Center for Individualized Medicine , Mayo Clinic , Rochester , Minnesota , USA 4 Bioinformatics Research and Development Laboratory, Genomics Sciences and Precision Medicine Center , Medical College of Wisconsin , Milwaukee , Wisconsin , USA 5 Autism & Developmental Medicine Institute , Geisinger-Lewistown Hospital , Lewistown , Pennsylvania ...
12/8/2021 FDA Takes New Steps Aimed at Advancing Development of Individualized Medicines to Treat Genetic Diseases lifepronow.com December 07, 2021: “The following quote is attributed to Acting FDA Commissioner Janet Woodcock, M.D.“Progress in individualized medicines provides hope to patients with severely debilitating or life-threatening genetic diseases.Advances in technology enable targeting a drug to an individual patient’s genes. Single-subject clinical trials—also called ‘N of 1’ trials—focus on evaluating investigational drug products developed for an individual patient.This field is rapidly ...
12/7/2021 FDA In Brief: FDA Takes New Steps Aimed at Advancing Development of Individualized Medicines to Treat Genetic Diseases fda.gov The following quote is attributed to Acting FDA Commissioner Janet Woodcock, M.D. “Progress in individualized medicines provides hope to patients with severely debilitating or life-threatening genetic diseases. Advances in technology enable targeting a drug to an individual patient’s genes. Single-subject clinical trials—also called ‘N of 1’ trials—focus on evaluating investigational drug products developed for an individual patient. This field is rapidly evolving, and antisense ...
11/30/2021 Genetic variants influence migraine treatment response, according to new Mayo study - Mayo Clinic Press Mayo Clinic ... long and complex process. Patients often cycle through medications for weeks or months until achieving a therapeutic response.Now after years of slow progress in migraine therapies and advancements, a Mayo Clinic Center for Individualized Medicine researcher has discovered variants in six genes that could shed light on what triggers the debilitating condition and provide a potential step toward guiding individualized treatments.The new research, led by Fred Cutrer, M.D ...
10/12/2021 Mayo Clinic taps Personalis for genome sequencing to guide cancer therapy and R FierceBiotech ... at the clinic."We believe the use of aggregated and de-identified genomic sequencing data will improve both patient care and patient access to care," Konstantinos Lazaridis, medical director of Mayo’s Center for Individualized Medicine , said in a statement .RELATED: Google solidifies Mayo Clinic ties with Rochester office spaceEarlier this year, Personalis reported that it has delivered more than 140,000 sequenced human genomes to the U.S. Department of ...
10/12/2021 Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing Business Wire ... decisions, advance cancer research, and support the development of new diagnostic tests and therapies for cancer treatment. Mayo Clinic Cancer Center , Mayo Clinic's Department of Laboratory Medicine and Pathology , and Mayo Clinic's Center for Individualized Medicine are collaborating with Personalis Inc. (Nasdaq: PSNL), a cancer genomics company whose clinical-grade, comprehensive cancer genomic test includes sequencing the entire coding genome through whole-exome and transcriptome sequencing. The test will provide ...
10/12/2021 Mayo Clinic collaborates with Personalis Inc. to expand cancer genomic testing Mayo Clinic ... decisions, advance cancer research, and support the development of new diagnostic tests and therapies for cancer treatment. Mayo Clinic Cancer Center , Mayo Clinic's Department of Laboratory Medicine and Pathology , and Mayo Clinic's Center for Individualized Medicine are collaborating with Personalis Inc. (Nasdaq: PSNL), a cancer genomics company whose clinical-grade, comprehensive cancer genomic test includes sequencing the entire coding genome through whole-exome and transcriptome sequencing. The test will provide ...
10/12/2021 Mayo Clinic Collaborates With Personalis Inc. to Expand Cancer Genomic Testing | Financial Buzz financialbuzz.com ... cancer research, and support the development of new diagnostic tests and therapies for cancer treatment.Mayo Clinic Cancer Center , Mayo Clinic’s Department of Laboratory Medicine and Pathology , and Mayo Clinic’s Center for Individualized Medicine are collaborating with Personalis Inc. (Nasdaq: PSNL), a cancer genomics company whose clinical-grade, comprehensive cancer genomic test includes sequencing the entire coding genome through whole-exome and transcriptome sequencing. The test will provide ...
10/7/2021 Expert Alert: Advancing individualized medicine through genomics Mayo Clinic By Colette Gallagher Expert Alert: Advancing individualized medicine through genomics ROCHESTER, Minn. – The virtual 10th Annual Individualizing Medicine Conference on Oct. 8–9 will highlight the latest discoveries, diagnostics, therapeutics and emerging approaches in the field of genomics. Attendees will hear from renowned experts and learn first-hand how individualized medicine is transforming clinical practice, research and education. Highlighted topics will include artificial intelligence, health disparities, precision oncology, microbiome ...